Real patient outcomes from our nuclear medicine team.

For patients researching their options.

The decision to start radioligand therapy is an important one. Most patients we meet have done significant research before they walk into our consultation room — comparing therapy options, reading about outcomes, and trying to understand what to realistically expect. Patient-specific case studies bridge the gap between general treatment descriptions and what therapy actually looks like in practice.

Each case below documents a specific clinical scenario, the therapy our team chose, the imaging response, the symptom relief, and the measurable change in disease markers (PSA, Chromogranin A, tumour volume). Where a case scenario has also been described in a published peer-reviewed paper from our team, we link the publication. Plain-language summaries make these accessible whether you are a prospective patient, family member, or referring physician.